(6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide

C39H45F2N9O4 — CID 149083917

IUPAC(6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide
SMILESC=CCN1CC(=O)N2C(=CN(Cc3cccc(N4CC(N5CCN(C)CC5C)C4)n3)C(=O)[C@@H]2Cc2c(F)cc(O)cc2F)N1C(=O)NCc1ccccc1
InChIInChI=1S/C39H45F2N9O4/c1-4-13-47-25-37(52)49-34(18-31-32(40)16-30(51)17-33(31)41)38(53)46(24-36(49)50(47)39(54)42-19-27-9-6-5-7-10-27)21-28-11-8-12-35(43-28)45-22-29(23-45)48-15-14-44(3)20-26(48)2/h4-12,16-17,24,26,29,34,51H,1,13-15,18-23,25H2,2-3H3,(H,42,54)/t26?,34-/m0/s1
InChIKeyQQWGBDXEOSZSGU-BFZOCEIISA-N
MW741.84 g/mol
LogP3.10
Rot. Bonds10

About (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide

(6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide (PubChem CID 149083917) has the molecular formula C39H45F2N9O4 and a molecular weight of 741.84 g/mol. Its IUPAC name is (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide.

Molecular Properties

Compound Name(6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide
PubChem CID149083917
Molecular FormulaC39H45F2N9O4
Molecular Weight741.84 g/mol
Exact Mass741.36
IUPAC Name(6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide
SMILESC=CCN1CC(=O)N2C(=CN(Cc3cccc(N4CC(N5CCN(C)CC5C)C4)n3)C(=O)[C@@H]2Cc2c(F)cc(O)cc2F)N1C(=O)NCc1ccccc1
InChIInChI=1S/C39H45F2N9O4/c1-4-13-47-25-37(52)49-34(18-31-32(40)16-30(51)17-33(31)41)38(53)46(24-36(49)50(47)39(54)42-19-27-9-6-5-7-10-27)21-28-11-8-12-35(43-28)45-22-29(23-45)48-15-14-44(3)20-26(48)2/h4-12,16-17,24,26,29,34,51H,1,13-15,18-23,25H2,2-3H3,(H,42,54)/t26?,34-/m0/s1
InChIKeyQQWGBDXEOSZSGU-BFZOCEIISA-N
XLogP3.10
TPSA119.04 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds10
Heavy Atoms54
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500741.84
LogP ≤ 53.10
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide?
The IUPAC name of (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide (CID 149083917) is (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide.
What is the SMILES notation for (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide?
The canonical SMILES for (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide is C=CCN1CC(=O)N2C(=CN(Cc3cccc(N4CC(N5CCN(C)CC5C)C4)n3)C(=O)[C@@H]2Cc2c(F)cc(O)cc2F)N1C(=O)NCc1ccccc1.
What is the InChIKey of (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide?
The InChIKey is QQWGBDXEOSZSGU-BFZOCEIISA-N. The full InChI is InChI=1S/C39H45F2N9O4/c1-4-13-47-25-37(52)49-34(18-31-32(40)16-30(51)17-33(31)41)38(53)46(24-36(49)50(47)39(54)42-19-27-9-6-5-7-10-27)21-28-11-8-12-35(43-28)45-22-29(23-45)48-15-14-44(3)20-26(48)2/h4-12,16-17,24,26,29,34,51H,1,13-15,18-23,25H2,2-3H3,(H,42,54)/t26?,34-/m0/s1.
What are the key properties of (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide?
(6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide has a molecular weight of 741.84 g/mol, XLogP of 3.10, 10 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (6S)-N-benzyl-6-[(2,6-difluoro-4-hydroxyphenyl)methyl]-8-[[6-[3-(2,4-dimethylpiperazin-1-yl)azetidin-1-yl]-2-pyridinyl]methyl]-4,7-dioxo-2-prop-2-enyl-3,6-dihydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide is sourced from PubChem (CID 149083917), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).